IRIS PubliCatt

Fasano, Alfonso
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.173
NA - Nord America 2.728
AS - Asia 960
AF - Africa 29
OC - Oceania 14
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.917
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.710
DE - Germania 1.259
SE - Svezia 514
CN - Cina 448
UA - Ucraina 333
SG - Singapore 257
IT - Italia 246
FR - Francia 202
IE - Irlanda 164
GB - Regno Unito 159
ID - Indonesia 86
FI - Finlandia 83
IN - India 77
RU - Federazione Russa 71
PL - Polonia 60
TR - Turchia 26
CI - Costa d'Avorio 21
JP - Giappone 21
NL - Olanda 21
BE - Belgio 15
AU - Australia 13
IR - Iran 13
CA - Canada 11
HK - Hong Kong 10
ES - Italia 8
MX - Messico 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
BG - Bulgaria 5
RO - Romania 5
BR - Brasile 4
CH - Svizzera 4
EU - Europa 4
IL - Israele 4
KE - Kenya 4
DK - Danimarca 3
GR - Grecia 3
HU - Ungheria 3
KR - Corea 3
VN - Vietnam 3
CZ - Repubblica Ceca 2
LT - Lituania 2
PT - Portogallo 2
TW - Taiwan 2
AM - Armenia 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 6.917
Salva come PNG Salva come JPEG
Città #
Chandler 589
Ashburn 216
Singapore 198
Jacksonville 170
Dublin 161
San Mateo 145
Nanjing 97
Wilmington 93
Jakarta 86
Ann Arbor 79
New York 75
Nürnberg 75
Dearborn 70
Woodbridge 65
Boston 62
Lawrence 58
Warsaw 56
Houston 54
Seattle 48
Fairfield 46
Milan 45
Lancaster 42
Marseille 42
Beijing 41
Nanchang 38
Redwood City 35
Cattolica 33
Moscow 32
Munich 29
Redmond 27
University Park 26
Mountain View 25
Norwalk 24
Princeton 24
Shenyang 23
Bremen 22
Izmir 22
Jiaxing 22
Abidjan 21
Rome 21
Leawood 20
Changsha 18
Hangzhou 17
Hebei 17
Boardman 16
Brussels 15
London 15
Shanghai 15
Los Angeles 14
Tianjin 14
Fremont 13
Pune 13
Cambridge 12
Lappeenranta 12
Simi Valley 12
Kunming 11
Zhengzhou 11
Chicago 10
Augusta 9
Poitiers 9
Phoenix 8
Falls Church 7
Guangzhou 7
Amsterdam 6
Columbus 6
Detroit 6
Fort Worth 5
Fuzhou 5
Helsinki 5
Hong Kong 5
Lanzhou 5
Taizhou 5
Tehran 5
Toronto 5
Vienna 5
Brisbane 4
Bronxville 4
Chelmsford 4
Chennai 4
Costa Mesa 4
Dubai 4
Jinan 4
Locarno 4
São Paulo 4
Tokyo 4
Andover 3
Berlin 3
Castelfidardo 3
Central 3
Chengdu 3
Cologne 3
Edinburgh 3
Frankfurt am Main 3
Gergei 3
Hefei 3
Mexico 3
Padova 3
Philadelphia 3
Stockholm 3
Tappahannock 3
Totale 3.480
Salva come PNG Salva come JPEG
Nome #
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 197
The role of small intestinal bacterial overgrowth in Parkinson's disease 182
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 144
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. 137
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 136
PUNDING IN PARKINSON'S DISEASE: THE IMPACT OF PATIANT'S AWARENESS ON DIAGNOSIS 132
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 129
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study 125
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation 120
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 120
Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease 117
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 115
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 115
Prevalence of small intestinal bacterial overgrowth in Parkinson's disease 112
Unilateral extradural motor cortex stimulation is safe and improves Parkinson disease at 1 year 109
Movement disorders in multiple sclerosis: Causal or coincidental association? 105
Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. 104
Aristotle's illusion reveals interdigit functional somatosensory alterations in focal hand dystonia 102
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 102
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 101
Analysis of blink rate in patients with blepharospasm 99
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 99
Dystonia gravidarum: a new case with a long follow-up 98
Depression Symptoms and Clinical Subtypes in Parkinson's Disease Patients: a I-123-FP-CIT SPECT Study 97
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 97
Reliability of Clinical Diagnosis of Dystonia 94
New olfactometric findings in Parkinson's disease 94
Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature 91
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report 91
Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability 91
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT study: reply to comment by Erro et al. 91
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis 91
Homotoxicology remedies versu desmopressin versus placebo in the treatment of enuresis: a randomised, double-blind, controlled trial. 90
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs 90
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease 90
Tourettism in multiple sclerosis: a case report 89
MANAGEMENT OF PUNDING IN PARKINSON'S DISEASE: AN OPEN-LABEL PROSPECTIVE STUDY 89
GPi-DBS in Huntington's disease: results on motor function and cognition in a 72-year-old case 88
Alpha-synuclein gene duplication: marked intrafamilial variability in two novel pedigrees 88
Reduced facial expressiveness in Parkinson's disease: A pure motor disorder? 88
Working on asymmetry in Parkinson's disease: randomized, controlled pilot study 87
Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis 86
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm 86
Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity 82
Safety and efficacy of rotigotine in individuals with Parkinson's disease aged 75 and older 81
Management of status dystonicus: our experience and review of the literature 81
Punding and computer addiction in Parkinson's disease 80
The long-term effect of tetrabenazine in the management of Huntington disease 80
Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome. 79
RARE AND SERIOS CARDIAC SIDE EFFECTS DURING ROPINIROLE TITRATION 76
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 76
Freezing of gait in Parkinson's disease: the paradoxical interplay between gait and cognition 76
Humanitarian mission improves health conditions of schoolchildren in Ethiopia. the case of Adwa 74
Acute necrotizing encephalopathy: a relapsing case in a European adult 73
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 73
Onset and progression of primary torsion dystonia in sporadic and familial cases 72
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson’s disease: Need for long-term trials. 72
Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding 72
Rare and serious cardiac side effects during ropinirole titration 69
Increased excretion of glycosaminoglycans in children with urinary incontinence compared to those with monosymptomatic nocturnal enuresis 68
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 67
Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study 66
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 65
Movement disorders phenomenology in focal motor seizures 61
Long-term consequences of optical coherence tomography findings during percutaneous coronary intervention: The Centro per la Lotta Contro L'infarto - Optimization of Percutaneous Coronary Intervention (CLI-OPCI) LATE study 59
Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion 58
Status dystonicus: predictors of outcome and progression patterns of underlying disease 56
Functional disorders after COVID-19 vaccine fuel vaccination hesitancy 55
Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life 54
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 54
Long-term effects of pedunculopontine nucleus stimulation for pisa syndrome 53
Punding (PD) 52
Randomized comparison of optical coherence tomography versus angiography to guide Bioresorbable vascular scaffold implantation: The OPTICO BVS study 49
Role of optical coherence tomography for distal left main stem angioplasty 48
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts 48
Treatment of dystonia using trihexyphenidyl in costello syndrome 47
Retrospective evaluation of the dose equivalence of Botox and Dysport in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story 42
Pisa syndrome in Parkinson disease 42
Tetrabenazine 41
Implementation of the Current Dystonia Classification from 2013 to 2018 40
Psychogenic facial movement disorders: Clinical features and associated conditions 34
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: Need for long-term clinical trials 15
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: From the advanced phase towards the late stage of the disease? 9
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease. 3
Totale 7.010
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.781
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020602 0 0 0 0 50 82 89 51 55 59 118 98
2020/2021801 61 83 10 75 94 33 75 27 104 81 143 15
2021/2022810 67 81 20 45 46 26 21 126 35 69 118 156
2022/20231.606 190 217 123 232 118 202 83 145 194 21 59 22
2023/2024718 39 215 21 31 13 110 38 36 11 34 101 69
2024/2025368 23 49 124 48 124 0 0 0 0 0 0 0
Totale 7.010